MT-1207

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameMT-1207
Drug Alias NameMT-1207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsVoltage-gated calcium channel blockersAlpha adrenergic receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorVoltage-gated calcium channelAlpha adrenergic receptor
Therapy Area/IndicationsHypertensionProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLiaoning Green Biological Pharmaceutical Group Co LtdShenyang Haiwang Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenyang Haiwang Biotechnology Co LtdLiaoning Green Biological Pharmaceutical Group Co Ltd
Inactive CompaniesLiaoning Green Biopharmaceutical Group Co Ltd
Active IndicationsHypertensionProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A